PolyProx Therapeutics is a biotechnology company. Founded in 2019, PolyProx Therapeutics is backed by investors that include Cambridge Innovation Capital, Rt Capital Management, and University of Cambridge Enterprise. PolyProx Therapeutics is headquartered in Cambridge.
FOUNDED:
2019
INDUSTRY:
Health Care, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
